Clot lysis methods are used extensively in fibrinolytic work both for research into the physiology of the fibrinolytic system and for assay and standardization of enzymes. The following is a description of a simple method for measuring partial clot lysis using cheap and easily available apparatus and reagents. The method was first described by Blix in 1962 and has been adapted to suit the apparatus available and the subject being investigated.
The principle is as follows: a fibrin clot containing red blood cells is made and exposed to a fibrinolytic enzyme. As the clot lyses, red cells are released from it and the amount of lysis occurring in a given time can be found by measuring the number of cells released.
A clot of 1 ml. volume is made in a lusteroid tube measuring 11 x 54 mm. and its composition is shown diagrammatically in Figure 1 0-1 ml. (Leo thrombin reagent 50 units/ml.), red blood cells 0-1 ml. (packed platelet-free human red cells which have been washed four times), and buffer 'space' 0 7 ml. The clot is buffered to pH 7-2. Group 0 red cells are used because human serum fractions added to the clot may contain blood group antibodies. The 07 ml. buffer 'space' is used for the addition of components of the fibrinolytic system so that their effect on clot lysis can be measured. Also any substance whose function in the fibrinolytic system is unknown can be substituted for buffer 'space' and its activity as an inhibitor or an enzyme may be assessed.
To ensure that the red cells are distributed evenly throughout the clot, fibrinogen is added last, the tube stoppered and inverted rapidly three times. The tube is then left standing upside down on its stopper thus making it easy to extract the clot without breaking it. After at least 30 minutes the clot is gently transferred to a petri dish containing physiological saline in order to remove any loose red cells. From the petri dish it is moved to a polythene container measuring 13 x 30 mm. with a push-on lid and having in it 2 ml. of fluid in which the clot floats. The nature of this fluid depends upon the experiment being carried out: it may be buffer, any known component of the fibrinolytic system, or any substance whose effect on fibrinolysis one wishes to discover. Some examples will be given later to make this clearer.
The polythene container and clot are now placed in a 37°C. incubator on a rotating device. (Blix (1962) used a record player but a Matburn mixer is quite suitable.) As the clot lyses, red cells are released into the surrounding fluid and after a certain time the clot is lifted out of the container and the number of red cells in the surrounding fluid measured. To do this 0 5 ml. of the fluid containing the red cells is transferred to 4 ml. of 0 04 % ammonium hydroxide and read in a spectrophotometer at a wavelength of 542 mu against a blank in which 0-5 ml. of saline is used in place of the red cell suspension. The reading obtained on the spectrophotometer is converted to the percentage of total clot lysis by making a calibration curve with the same batch of red cells as was used in the clot, in which the 100% value is equivalent to all the red cells in the clot being released into the surrounding fluid. Each experiment is performed in duplicate and the mean percentage lysis taken in every case. (Table II) , and the results in Table III show the inclusion of lipoprotein in the surrounding fluid to be equally ineffective. To illustrate possible uses of the method some of the results obtained with it are shown below. The effect of human serum lipoproteins upon the various components of the human fibrinolytic system was being investigated. It was thought possible that lipoproteins might block plasminogen activation, or the action of plasmin itself, or that they might enhance the activity of the antiplasmins, or simply interfere mechanically with the diffusion of activator into a clot.
Low-density lipoprotein was obtained by highspeed centrifugation of normal non-lipaemic human serum. At the end of 14 hours at 40,000 r.p.m. this lipoprotein fraction is in the upper one sixth of the tube and can be pipetted off. A fibrinolytic enzyme was prepared by the method described by Blix (1962) in which venous blood with high activator content is taken from an arm rendered ischaemic by maintaining a sphygmomanometer cuff at 90 mm. of mercury for five minutes. From the platelet-poor plasma the euglobulin fraction is precipitated using a strictly applied cold technique, resuspended in buffer, clotted with thrombin, the clot squeezed and transferred to a tube of buffer where it lyses, releasing 'lysed products' containing activator and plasmin into the buffer. 
